BLOG / 🇺🇸 United States · · daily

High-Value Federal Grants ($5M+) — June 10, 2026

High-Value Federal Grants ($5M+)

By Gunpowder Editorial ·

5 total filings analysed

Executive Summary

This digest covers $1.18B in high-value federal contracts awarded on June 10, 2026, with a 2/5 defense-related split, though the largest award—a $777M CACI NSS delivery order for special operations support—dominates the aggregate.

The civilian side is led by a $125.5M Icahn School of Medicine CDC contract (now expired) and a $92.8M BARDA award to private firm Tunnell Consulting for biodefense R&D, signaling sustained biosecurity investment. The highest-conviction signal is the CACI award, which is bullish for defense services given its full-and-open competitive win and high-priority mission, but the cost-plus structure limits margin upside. Key risks include the negative outlay on the Amentum $91.7M GSA contract, suggesting funding timing uncertainty, and the expiration of the Icahn contract, which removes a revenue stream. Investors should watch for option exercises on CACI's $1.13B potential ceiling and Tunnell Consulting's long-dated BARDA options extending to 2035.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from June 06, 2026.

Investment Signals (5)

  • CACI Wins $777M Special Operations Support Contract, Validating Competitive Moat (HIGH)

    CACI International Inc. won a $777M cost-plus award fee delivery order from GSA for Special Operations Forces Emerging Threats Operations and Planning Support at Fort Bragg, with options bringing total potential to $1.13B. The full-and-open competition with no set-aside confirms CACI's strong market position in this niche defense services area.

  • Amentum Services Secures $91.7M GSA Engineering Contract with $211.9M Upside (MEDIUM)

    Amentum Services, Inc. won a $91.7M delivery order from GSA for engineering and program management support, with options potentially increasing total to $211.9M. The full-and-open competitive award provides multi-year revenue visibility through mid-2025, though negative outlays (-$29k) warrant monitoring.

  • Icahn School of Medicine CDC Contract Expired—$125.5M Revenue Stream Ended (HIGH)

    The $125.5M cost-no-fee contract with the CDC for the World Trade Center Health Program Clinical Center of Excellence ended in 2022, with only $32.9M outlayed. This removes a stable, low-risk revenue source for the nonprofit, though no direct public equity impact.

  • Tunnell Consulting's $660.2M BARDA Ceiling Signals Long-Term Biodefense Investment (MEDIUM)

    Tunnell Consulting Inc. won a $92.8M delivery order from BARDA with a base-plus-options ceiling of $660.2M extending to 2035 for biotech R&D support. This signals sustained government commitment to biodefense and pandemic preparedness, though the company is private, limiting direct investment.

  • Caltech JPL FFRDC Contract Non-Competitive—No Direct Public Investment Opportunity (LOW)

    The $92.5M non-competitive, cost-plus-fixed-fee NASA delivery order to Caltech for JPL high-performance spaceflight computing R&D provides stable revenue but is not investable as Caltech is a private nonprofit. The award signals continued NASA space computing investment, which may benefit public contractors indirectly.

Risk Flags (4)

  • Execution [MEDIUM RISK]

    Amentum Services' $91.7M GSA contract shows negative outlays (-$29k), suggesting possible funding adjustments or payment delays that could impact cash flow timing and execution.

  • Budget [MEDIUM RISK]

    The CACI $777M contract's cost-plus structure limits margin upside and exposes the company to potential cost overruns or government audit risk, especially under a Continuing Resolution scenario that could delay option exercises.

  • Concentration [MEDIUM RISK]

    The digest shows two contracts (CACI $777M and Amentum $91.7M) both awarded by GSA, representing 73.5% of total obligation value. Over-reliance on GSA as a contracting vehicle could create vulnerability if GSA procurement policies shift or budgets are cut.

  • Competition [LOW RISK]

    The Icahn School of Medicine's $125.5M CDC contract has expired, and the re-compete for the World Trade Center Health Program Clinical Center of Excellence could go to a competitor, potentially shifting market share in healthcare services.

Opportunities (3)

  • CACI's $777M special operations support contract positions the company for follow-on work in the high-priority SOF mission area. The $1.13B potential ceiling offers significant revenue upside if all options are exercised, reinforcing CACI's competitive moat in defense services.

  • Tunnell Consulting's $92.8M BARDA award with a $660.2M ceiling extending to 2035 signals sustained government investment in biodefense and medical countermeasure R&D. If Tunnell goes public or is acquired, this contract provides a strong revenue base for investors.

  • Amentum Services' $91.7M GSA contract with $211.9M potential ceiling offers multi-year revenue visibility through 2025. The full-and-open competitive win validates Amentum's market position in engineering and program management, and option exercises could drive upside.

Sector Themes (3)

  • CACI's $777M contract for Special Operations Forces Emerging Threats Operations and Planning Support at Fort Bragg underscores the DOD's continued prioritization of SOF capabilities, a durable budget line item even under CR scenarios.

  • Tunnell Consulting's $92.8M BARDA award with a $660.2M ceiling extending to 2035 reflects the government's long-term commitment to biodefense R&D, a theme accelerated by recent pandemic experiences.

  • Two of the five contracts (CACI $777M and Amentum $91.7M) were awarded through GSA, representing 73.5% of total obligation value. This highlights GSA's role as a key procurement vehicle for defense and civilian professional services.

Watch List (4)

  • 👁

    {"entity"=>"CACI International Inc.", "reason"=>"Won the largest contract in the digest ($777M) with $1.13B potential ceiling for special operations support, a high-priority defense area.", "trigger"=>"Option exercise announcements for the $1.13B ceiling; quarterly revenue reports showing contract contribution"}

  • 👁

    {"entity"=>"Amentum Services, Inc.", "reason"=>"Negative outlays (-$29k) on $91.7M GSA contract suggest funding timing uncertainty; option exercises could drive upside.", "trigger"=>"Outlay direction resolution; option exercise timeline after current obligation"}

  • 👁

    {"entity"=>"Tunnell Consulting Inc.", "reason"=>"Private company with $660.2M BARDA ceiling extending to 2035; potential IPO or acquisition could create public equity opportunity.", "trigger"=>"Option exercise announcements; any news of IPO or acquisition"}

  • 👁

    {"entity"=>"Icahn School of Medicine at Mount Sinai", "reason"=>"Expired $125.5M CDC contract; re-compete for WTC Health Program could shift market share.", "trigger"=>"Follow-on contract announcements for World Trade Center Health Program Clinical Center of Excellence"}

Get daily alerts with 5 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 5 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: High-Value Federal Grants ($5M+)

🇺🇸 More from United States

View all →